Literature DB >> 33098755

Informed consent procedures for emergency interventional research in patients with traumatic brain injury and ischaemic stroke.

Erwin J O Kompanje1, Jeroen T J M van Dijck2, Vicky Chalos3, Sophie A van den Berg4, Paula M Janssen5, Paul J Nederkoorn6, Mathieu van der Jagt7, Giuseppe Citerio8, Nino Stocchetti9, Diederik W J Dippel5, Wilco C Peul2.   

Abstract

Health-care professionals and researchers have a legal and ethical responsibility to inform patients before carrying out diagnostic tests or treatment interventions as part of a clinical study. Interventional research in emergency situations can involve patients with some degree of acute cognitive impairment, as is regularly the case in traumatic brain injury and ischaemic stroke. These patients or their proxies are often unable to provide informed consent within narrow therapeutic time windows. International regulations and national laws are criticised for being inconclusive or restrictive in providing solutions. Currently accepted consent alternatives are deferred consent, exception from consent, or waiver of consent. However, these alternatives appear under-utilised despite being ethically permissible, socially acceptable, and regulatorily compliant. We anticipate that, when the requirements for medical urgency are properly balanced with legal and ethical conduct, the increased use of these alternatives has the potential to improve the efficiency and quality of future emergency interventional studies in patients with an inability to provide informed consent.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 33098755     DOI: 10.1016/S1474-4422(20)30276-3

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  10 in total

1.  Brief Consent Methods Enable Rapid Enrollment in Acute Stroke Trial: Results From the TICH-2 Randomized Controlled Trial.

Authors:  Zhe Kang Law; Jason P Appleton; Polly Scutt; Ian Roberts; Rustam Al-Shahi Salman; Timothy J England; David J Werring; Thompson Robinson; Kailash Krishnan; Robert A Dineen; Ann Charlotte Laska; Philippe A Lyrer; Juan Jose Egea-Guerrero; Michal Karlinski; Hanne Christensen; Christine Roffe; Daniel Bereczki; Serefnur Ozturk; Jegan Thanabalan; Ronan Collins; Maia Beridze; Alfonso Ciccone; Lelia Duley; Angela Shone; Philip M Bath; Nikola Sprigg
Journal:  Stroke       Date:  2021-12-01       Impact factor: 7.914

2.  Exploring the inclusion of under-served groups in trials methodology research: an example from ethnic minority populations' views on deferred consent.

Authors:  Timia Raven-Gregg; Victoria Shepherd
Journal:  Trials       Date:  2021-09-03       Impact factor: 2.728

3.  Outcome Prognostication of Acute Brain Injury using the Neurological Pupil Index (ORANGE) study: protocol for a prospective, observational, multicentre, international cohort study.

Authors:  Mauro Oddo; Fabio Taccone; Stefania Galimberti; Paola Rebora; Giuseppe Citerio
Journal:  BMJ Open       Date:  2021-05-11       Impact factor: 2.692

4.  Safety and efficacy of C1-inhibitor in traumatic brain injury (CIAO@TBI): study protocol for a randomized, placebo-controlled, multi-center trial.

Authors:  Inge A M van Erp; Thomas A van Essen; Kees Fluiter; Erik van Zwet; Peter van Vliet; Frank Baas; Iain Haitsma; Dagmar Verbaan; Bert Coert; Godard C W de Ruiter; Wouter A Moojen; Mathieu van der Jagt; Wilco C Peul
Journal:  Trials       Date:  2021-12-04       Impact factor: 2.279

5.  Ethical Considerations in Clinical Trials for Disorders of Consciousness.

Authors:  Michael J Young; Yelena G Bodien; Brian L Edlow
Journal:  Brain Sci       Date:  2022-02-02

6.  Deferred Consent in an Acute Stroke Trial from a Patient, Proxy, and Physician Perspective: A Cross-Sectional Survey.

Authors:  Inez Koopman; Dagmar Verbaan; W Peter Vandertop; Rieke van der Graaf; Erwin J O Kompanje; René Post; Bert A Coert; Martine C Ploem; Wouter M Sluis; Féline E V Scheijmans; Gabriel J E Rinkel; Mervyn D I Vergouwen
Journal:  Neurocrit Care       Date:  2021-10-05       Impact factor: 3.210

7.  Randomized Evaluation of Surgery in Elderly with Traumatic Acute SubDural Hematoma (RESET-ASDH trial): study protocol for a pragmatic randomized controlled trial with multicenter parallel group design.

Authors:  Jeroen T J M van Dijck; Thomas A van Essen; Ranjit D Singh; Hester F Lingsma; Suzanne S Polinder; Erwin J O Kompanje; Erik W van Zwet; Ewout W Steyerberg; Godard C W de Ruiter; Bart Depreitere; Wilco C Peul
Journal:  Trials       Date:  2022-03-29       Impact factor: 2.279

8.  Patient and proxies' attitudes towards deferred consent in randomised trials of acute treatment for stroke: A qualitative survey.

Authors:  Noa van den Bos; Sophie A van den Berg; Catalina Mm Caupain; Jeannette Aj Pols; Tessa van Middelaar; Vicky Chalos; Diederik Wj Dippel; Yvo Bwem Roos; Manon Kappelhof; Paul J Nederkoorn
Journal:  Eur Stroke J       Date:  2021-11-13

9.  Outcome Prediction Based on Automatically Extracted Infarct Core Image Features in Patients with Acute Ischemic Stroke.

Authors:  Manon L Tolhuisen; Jan W Hoving; Miou S Koopman; Manon Kappelhof; Henk van Voorst; Agnetha E Bruggeman; Adam M Demchuck; Diederik W J Dippel; Bart J Emmer; Serge Bracard; Francis Guillemin; Robert J van Oostenbrugge; Peter J Mitchell; Wim H van Zwam; Michael D Hill; Yvo B W E M Roos; Tudor G Jovin; Olvert A Berkhemer; Bruce C V Campbell; Jeffrey Saver; Phil White; Keith W Muir; Mayank Goyal; Henk A Marquering; Charles B Majoie; Matthan W A Caan
Journal:  Diagnostics (Basel)       Date:  2022-07-23

10.  Dual thrombolytic therapy with mutant pro-urokinase and small bolus alteplase for ischemic stroke (DUMAS): study protocol for a multicenter randomized controlled phase II trial.

Authors:  Nadinda A M van der Ende; Bob Roozenbeek; Lucas E M Smagge; Sven P R Luijten; Leo A M Aerden; Petra Kraayeveld; Ido R van den Wijngaard; Geert J Lycklama À Nijeholt; Heleen M den Hertog; H Zwenneke Flach; Alexis C Wallace; Victor Gurewich; Gregory J Del Zoppo; William J Meurer; Hester F Lingsma; Aad van der Lugt; Diederik W J Dippel
Journal:  Trials       Date:  2022-08-09       Impact factor: 2.728

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.